ARIES Flu A/B & RSV Assay , REF 50-10020, UDI # 00840487100158

FDA Device Recall #Z-2284-2019 — Class II — February 20, 2019

Recall Summary

Recall Number Z-2284-2019
Classification Class II — Moderate risk
Date Initiated February 20, 2019
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Luminex Corporation
Location Austin, TX
Product Type Devices
Quantity N/A

Product Description

ARIES Flu A/B & RSV Assay , REF 50-10020, UDI # 00840487100158

Reason for Recall

Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.

Distribution Pattern

US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom

Lot / Code Information

Lot numbers and discontinue use by dates for Part Number 50-10020: AA7127 - Immediately; AA7206 - Immediately; AA7312 - 3/5/2019; AA7549 - 3/30/2019; AA7635 - 4/10/2019

Other Recalls from Luminex Corporation

Recall # Classification Product Date
Z-1903-2025 Class II VERIGENE Gram Negative Blood Culture (BC-GN) Nu... Apr 16, 2025
Z-2533-2024 Class II Verigene Gram Positive Blood Culture (BC-GP) Nu... Jun 20, 2024
Z-0500-2024 Class II Luminex VERIGENE BC-GP Utility Tray (5-Pack Car... Nov 7, 2023
Z-2023-2023 Class II Verigene Enteric Pathogens Nucleic Acid Test (E... Jun 5, 2023
Z-2024-2023 Class II VERIGENE Clostridium difficile Nucleic Acid Tes... Jun 5, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.